These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26232236)

  • 1. Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21.
    Domouzoglou EM; Naka KK; Vlahos AP; Papafaklis MI; Michalis LK; Tsatsoulis A; Maratos-Flier E
    Am J Physiol Heart Circ Physiol; 2015 Sep; 309(6):H1029-38. PubMed ID: 26232236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine.
    Tan H; Yue T; Chen Z; Wu W; Xu S; Weng J
    Int J Biol Sci; 2023; 19(1):66-88. PubMed ID: 36594101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model.
    Maeng HJ; Lee GY; Bae JH; Lim S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.
    Liu C; Schönke M; Zhou E; Li Z; Kooijman S; Boon MR; Larsson M; Wallenius K; Dekker N; Barlind L; Peng XR; Wang Y; Rensen PCN
    Cardiovasc Res; 2022 Jan; 118(2):489-502. PubMed ID: 33693480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fibroblast growth factor 21 in atherosclerosis.
    Kokkinos J; Tang S; Rye KA; Ong KL
    Atherosclerosis; 2017 Feb; 257():259-265. PubMed ID: 28012645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 21 - a key player in cardiovascular disorders?
    Lenart-Lipińska M; Duma D; Hałabiś M; Dziedzic M; Solski J
    Horm Mol Biol Clin Investig; 2016 Jun; 30(2):. PubMed ID: 27305706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Correlation Between Serum Fibroblast Growth Factor 21 and the Severity and Occurrence of Coronary Artery Disease.
    Sinha SR; Prakash P; Keshari JR; Prasad RV
    Cureus; 2024 Jan; 16(1):e51924. PubMed ID: 38333506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibroblast growth factor 21 plays a protective role in cardiovascular diseases by inducing autophagy].
    Li YK; He SY; Wang C; Shi YC; Liu JH
    Sheng Li Xue Bao; 2022 Aug; 74(4):633-638. PubMed ID: 35993214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events.
    Wu L; Qian L; Zhang L; Zhang J; Zhou J; Li Y; Hou X; Fang Q; Li H; Jia W
    J Am Heart Assoc; 2020 Jun; 9(11):e015226. PubMed ID: 32431189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.
    Lin Z; Pan X; Wu F; Ye D; Zhang Y; Wang Y; Jin L; Lian Q; Huang Y; Ding H; Triggle C; Wang K; Li X; Xu A
    Circulation; 2015 May; 131(21):1861-71. PubMed ID: 25794851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 21 in chronic kidney disease.
    Suassuna PGA; de Paula RB; Sanders-Pinheiro H; Moe OW; Hu MC
    J Nephrol; 2019 Jun; 32(3):365-377. PubMed ID: 30430412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial FGF receptor signaling: angiogenic versus atherogenic effects.
    Williams JK
    Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H27-8. PubMed ID: 21057042
    [No Abstract]   [Full Text] [Related]  

  • 13. The roles of FGF21 in atherosclerosis pathogenesis.
    Tabari FS; Karimian A; Parsian H; Rameshknia V; Mahmoodpour A; Majidinia M; Maniati M; Yousefi B
    Rev Endocr Metab Disord; 2019 Mar; 20(1):103-114. PubMed ID: 30879171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oxidized low density lipoprotein and peroxisome proliferator-activated receptor α induced endogenous fibroblast growth factor 21 upregulation is protective against apoptosis in cardiac endothelial cells].
    Liu JH; Lü Y; Zhang LK; DU J; Zeng XJ; Hao G; Zhao DH; Wang GZ; Zhang YC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1113-7. PubMed ID: 21215149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?
    Kuro-O M
    Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
    Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis.
    Ong KL; Campbell S; Wu BJ; McClelland RL; Kokkinos J; Szklo M; Polak JF; Allison MA; Rye KA
    Atherosclerosis; 2019 Aug; 287():46-53. PubMed ID: 31212234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases.
    Cheung BM; Deng HB
    Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):659-66. PubMed ID: 24697521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
    Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
    Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases.
    Cheng P; Zhang F; Yu L; Lin X; He L; Li X; Lu X; Yan X; Tan Y; Zhang C
    J Diabetes Res; 2016; 2016():1540267. PubMed ID: 27247947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.